Tag: Phase III study

Browse exclusive Tags!

Alecensa Shows Promise in Reducing Recurrence in Early-Stage ALK-Positive Lung Cancer

Roche's Alecensa reduces recurrence in early-stage ALK-positive lung cancer, with potential for improved outcomes and increased chances of a cure. Promising results from the ALINA study. #LungCancer

First Patient Dosed in Phase III Study of TLX591-CDx Illuccix for Prostate Cancer Imaging in Chinese Patients, China

First Patient Dosed in Phase III Study of TLX591-CDx Illuccix for Prostate Cancer Imaging in Chinese Patients. Telix Pharmaceuticals and Grand Pharma collaborate to bring PSMA-PET imaging to Chinese men.

Popular

Alecensa Shows Promise in Reducing Recurrence in Early-Stage ALK-Positive Lung Cancer

Roche's Alecensa reduces recurrence in early-stage ALK-positive lung cancer, with potential for improved outcomes and increased chances of a cure. Promising results from the ALINA study. #LungCancer

Subscribe

spot_imgspot_img